Raymond James Maintains Outperform on Johnson & Johnson, Raises Price Target to $265

Benzinga Newsdesk www.benzinga.com Positive 91.5%

Neg 0% Neu 0% Pos 91.5%

Raymond James analyst Jayson Bedford maintains Johnson & Johnson (NYSE:JNJ) with a Outperform and raises the price target from $258 to $265.